Allstate Corporation’s Ionis Pharmaceuticals IONS Stock Holding History

Allstate Corporation’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	16,943 -3,622	-18%	-$273K	0.01%	636
2026 Q1	$1.54M	Buy	+20,565	New	+$1.62M	0.02%	619
2020 Q3	–	Sell	-3,974	Closed	-$234K	–	690
2020 Q2	$234K	Buy	+3,974	New	+$221K	0.01%	634
2019 Q4	–	Sell	-12,110	Closed	-$726K	–	624
2019 Q3	$726K	Buy	12,110 +7,667	+173%	+$500K	0.01%	411
2019 Q2	$286K	Buy	+4,443	New	+$314K	0.01%	454

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Allstate Corporation's IONS Position: Q2 2026 in Review

Allstate Corporation reduced its Ionis Pharmaceuticals (IONS) stake by 18% in Q2 2026, selling an estimated $273K and leaving 16,943 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #636.

Allstate Corporation first reported a position in IONS in Q2 2019 and has held it in 5 quarters since. The position peaked at $1.54M in Q1 2026. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Allstate Corporation held 16,943 shares of Ionis Pharmaceuticals worth $1.34M as of Q2 2026.
Allstate Corporation sold 3,622 Ionis Pharmaceuticals shares in Q2 2026, an estimated $273K.
Ionis Pharmaceuticals made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #636 holding.
Allstate Corporation first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
Allstate Corporation's Ionis Pharmaceuticals position peaked at $1.54M in Q1 2026.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.